Hydroxychloroquine versus Azithromycin for Hospitalized Patients with COVID-19. Results of a Randomized, Active Comparator Trial

Rationale: The coronavirus disease (COVID-19) pandemic struck an immunologically naive, globally interconnected population. In the face of a new infectious agent causing acute respiratory failure for which there were no known effective therapies, rapid, often pragmatic trials were necessary to evalu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Am Thorac Soc
Main Authors: Brown, Samuel M., Peltan, Ithan, Kumar, Naresh, Leither, Lindsay, Webb, Brandon J., Starr, Nathan, Grissom, Colin K., Buckel, Whitney R., Srivastava, Rajendu, Butler, Allison M., Groat, Danielle, Haaland, Benjamin, Ying, Jian, Harris, Estelle, Johnson, Stacy, Paine, Robert, Greene, Tom
Formato: Artigo
Idioma:Inglês
Publicado em: American Thoracic Society 2021
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8009003/
https://ncbi.nlm.nih.gov/pubmed/33166179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.202008-940OC
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados